{"id":14141,"date":"2025-11-26T14:28:07","date_gmt":"2025-11-26T13:28:07","guid":{"rendered":"https:\/\/okomeds.com\/?p=14141"},"modified":"2025-11-26T14:28:07","modified_gmt":"2025-11-26T13:28:07","slug":"the-five-most-common-mistakes-in-clinical-protocol-translation-and-how-to-prevent-them","status":"publish","type":"post","link":"https:\/\/okomeds.com\/es\/the-five-most-common-mistakes-in-clinical-protocol-translation-and-how-to-prevent-them\/","title":{"rendered":"The Five Most Common Mistakes in Clinical Protocol Translation \u2013 and How to Prevent Them"},"content":{"rendered":"

Imagine you\u2019ve got everything ready to launch an international clinical trial\u2026 and a single ambiguous sentence in the translated protocol delays approval by three months. It happens more often than you\u2019d think. In biomedical research, one word can mean the difference between an approved study and a stalled project.<\/p>\n

Clinical trial protocols<\/a> are the foundation of any study; they define objectives, methodology, inclusion criteria, and responsibilities. Translating them demands terminological precision, regulatory awareness, and a deep understanding of the scientific context. Yet errors are frequent \u2013 and costly.<\/p>\n

    \n
  1. \n
    \n
    \n

    Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n